智通财经APP获悉,今年以来,远大医药(00512)重磅利好消息频传,核药及危重症等领域的多项里程碑进展彰显了公司强大的创新实力。伴随着2025年中期业绩会以及投资者开放日活动的举办,公司进一步向市场彰显了其科技创新战略成效,同时也勾勒出其加速推进全球化创新发展的战略蓝图,远大医药或将迎来更为广阔的发展空间。中期财报数据显示,远大医药上半年收入再创历史新高,实现约61.1亿港元,若剔除集采影响,...
Source Link智通财经APP获悉,今年以来,远大医药(00512)重磅利好消息频传,核药及危重症等领域的多项里程碑进展彰显了公司强大的创新实力。伴随着2025年中期业绩会以及投资者开放日活动的举办,公司进一步向市场彰显了其科技创新战略成效,同时也勾勒出其加速推进全球化创新发展的战略蓝图,远大医药或将迎来更为广阔的发展空间。中期财报数据显示,远大医药上半年收入再创历史新高,实现约61.1亿港元,若剔除集采影响,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.